Business Wire

CARGILL

13.3.2024 09:01:38 CET | Business Wire | Press release

Share
Cargill Shares Outcome of the World’s First Wind-Powered Ocean Vessel’s Maiden Voyage

Cargill today revealed exciting results of the six-month test period of the Pyxis Ocean, underscoring the potential for the wind assisted propulsion technology in moving the shipping industry toward renewable energy use. The MC Shipping Kamsarmax vessel retrofitted with two WindWings® -large solid wind sails developed by BAR Technologies - - has achieved performance consistent with what was predicted which is equivalent to an average of 3 tonnes of fuel per day.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240313673847/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Pyxis Ocean sailing through the English Channel from Spain to Amsterdam, March 2024 (Photo: Business Wire)

“We are encouraged by the results and have learned a great deal about implementing wind assisted propulsion on dry bulk vessels,” said Jan Dieleman, president of Cargill’s Ocean Transportation business. “We could never have done this alone – BAR Technologies and MC Shipping and have been fantastic partners in making the Pyxis Ocean a reality as well as the captain and crew. We are on the leading edge of change in the shipping industry and believe technologies that harness the wind could be an important, cost-effective way to achieve our decarbonization goals in the short, medium and long-term.”

The Pyxis Ocean hit open waters in August 2023 and during the first six months of testing it has sailed the Indian Ocean, Pacific Ocean, North and South Atlantic, and passed Cape Horn and the Cape of Good Hope. The ship was retrofitted with two WindWings®, which measure 37.5 meters in height and resemble large airplane wings. The wings are installed vertically to catch the wind and propel the ship forward, allowing the ship’s engine to be turned down so that the ship can travel at the same speed as a conventional ship using less fuel. The wings are controlled by a touch panel on the bridge. A simple traffic light system tells the crew when to raise or lower the sails. Once raised, the operation is fully automated: sensors onboard constantly measure the wind, and the sails self-adjust to the optimal configuration.

Wind assisted propulsion has potential to be a cost-efficient way of supporting the International Maritime Organization's (IMO) new greenhouse gas strategy. One of the IMOs 2030 targets is to have 5 percent, striving for 10 percent, of energy coming from very low carbon sources by 2030: wind assisted propulsion could be an important way of achieving this.

The early voyages have provided insight on more than just the application of the sails on a vessel, it has also highlighted broader logistical challenges in the global maritime system. Given that every port, terminal, and berth is different, their involvement is critical towards integrating Wind Assisted Propulsion (WAP) technology into the global maritime system on a wider scale.

John Cooper, BAR Technologies CEO added, “The results of the Pyxis Ocean’s first voyage with WindWings® installed clearly demonstrate that wind assisted propulsion can secure significant fuel savings and emissions reduction. For example, in near optimum sailing conditions, during an open sea voyage, the Pyxis Ocean achieved fuel savings of 11 tonnes per day. And while the Pyxis Ocean has two WindWings®, we anticipate the majority of Kamsarmax vessels will carry three wings, further increasing the fuel savings and emissions reductions by a factor of 1.5. With Cargill we are now able to validate our performance predictions and modelling in real-world conditions, it’s an exciting time as we begin to roll out WindWings® production globally.”

“Cargill is creating ways for all WAP vessels - not just the Pyxis Ocean - to operate on global trade routes,” said Dieleman. “So far, we’ve engaged with more than 250 ports to find ways of enabling vessel with large scale WAP to berth. This complexity is where Cargill truly excels, and how we can leverage our unique role in the maritime industry. We are not afraid to be a development partner and invest, share risks with partners, and to make a difference in transforming the industry.”

Cargill will continue the testing and experimenting of operational, technical and commercial aspects of the Pyxis Ocean to incorporate the maximum amount of learning into potential design of future installations before scaling up.

Notes to editors:

[1]

  • BAR Technolgies and Cargill estimate an annual average savings of 3 tonnes of fuel reductions per day (this equates to 11,2/t/day CO2e well-to-wake emissions reductions. This equates to roughly 14 percent savings on Pyxis Ocean.
  • Average performance measured so far is within 10% of predictions made using computational fluid dynamics (CFD) simulations by BAR Technologies to estimate how well wind assisted propulsion would work on Cargill routes.
  • During optimal sailing conditions, the Pyxis Ocean achieved savings of more than 11t/day in fuel consumption, which translates to 41t/day less CO2e emitted well-to-wake, or a 37% emissions savings.
  • The 11.2t/day CO2e average above works out to be about 2650CO2e/yr (11.2t x 237 average sailing days per year = 2650t well-to-wake). This would be the equivalent of removing 480 cars off the road. (Reference: Greenhouse Gas Emissions from a Typical Passenger Vehicle | US EPA)
  • Cargill and MC Shipping have engaged DNV as an independent third party to review and verify the fuel savings calculations.

About WindWings

  • Cargill was the first to install “WindWings,” large solid wing sails with a potential to deliver double-digit percentage reductions in emissions.
  • Working with partner BAR Technologies, Cargill installed WindWings on a Kamsarmax vessel, Pyxis Ocean, that we are chartering from MC Shipping.
  • Installation was done at COSCO, in Shanghai, China in 2023.
  • Pyxis Ocean is now the most energy efficient Kamsarmax in Cargill’s fleet of chartered vessels
  • The Pyxis Ocean will be used to inform the potential scale-up across the fleet and industry. Cargill plans to continuously learn how to further improve design, operation, and performance.
  • The WindWing project is part of a project that has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 955286

About Cargill Ocean Transportation

Cargill Ocean Transportation is a leading freight-trading organization that charters around 650 vessels worldwide at any one time. Founded in 1956 in Geneva, we benefit from the rich heritage and expert capabilities of Cargill’s global operations in food, agriculture and commodities trading. Our customers, including other companies as well as Cargill’s own internal businesses, are at the center of everything we do. We provide services that combine the latest digital technology with green solutions to make shipping safer and more sustainable.

About Cargill

Cargill is committed to providing food, ingredients, agricultural solutions, and industrial products to nourish the world in a safe, responsible, and sustainable way. Sitting at the heart of the supply chain, we partner with farmers and customers to source, make and deliver products that are vital for living.

Our 160,000 team members innovate with purpose, providing customers with life’s essentials so businesses can grow, communities prosper, and consumers live well. With 159 years of experience as a family company, we look ahead while remaining true to our values. We put people first. We reach higher. We do the right thing—today and for generations to come. For more information, visit Cargill.com and our News Center

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240313673847/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro

Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release

Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a

Samsung Biologics Strike: Labor Union Warns of CDMO Supply Chain Risks Following Overwhelming Vote30.3.2026 11:52:00 CEST | Press release

Union members overwhelmingly approve strike action with 95.52% voting in favor on a 95.38% turnout, clearing the final legal hurdle after mediation ceased.Union emphasizes this is a fight against structural corporate governance issues, citing unresolved allegations concerning unfair labor practices and ESG compliance risks.Management adhered to a group-level wage guideline rather than bargaining on the basis of Samsung Biologics' own performance, exposing a lack of independent bargaining authority. The Samsung Biologics Labor Union (President: Jaesung Park), representing approximately 75% of the company's total employees, announced today that its members have overwhelmingly voted in favor of a strike, with 95.52% voting in favor on a 95.38% turnout during a voting period from March 24 to March 29. Following the Incheon Regional Labor Relations Commission's decision to cease mediation, the union has now secured the legal mandate to strike. The union stressed that this strike is not mere

The Premier Jumping League (PJL) Launches with a Record-Breaking $300 Million Guaranteed Prize Pot, Defining a New Era for Showjumping30.3.2026 11:00:00 CEST | Press release

The PJL empowers riders to compete as full-time professional athletes while working towards a sustainable economic model for the sport. Backed by McCourt Global and shaped by a leadership team with decades of experience in equestrian competition, sport, and entertainment, the PJL sets a new, sustainable, and globally relevant standard for elite jumping. Sixteen teams will compete across fourteen iconic international venues throughout Europe, North America, and the Middle East when the inaugural season opens in March 2027. The Premier Jumping League (PJL) launches with a record-breaking $300 million guaranteed prize pot, defining a new era for showjumping. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330990938/en/ Photography credits: Daniel Benson for The Premier Jumping League/ Wieden+Kennedy London Backed by McCourt Global and its Executive Chairman, Frank McCourt, the PJL is a groundbreaking global competition that e

Dompé Announces First Patient Enrolled in New Study of Intranasal NGF in Cerebral Palsy30.3.2026 11:00:00 CEST | Press release

Cerebral Palsy (CP) refers to a group of permanent disorders in the development of movement and posture, which causes activity limitations, and is attributed to non-progressive disturbances that occurred in the developing fetal or infant brain.1 Nerve growth factor (NGF) is a naturally-occurring protein that supports damaged nerve cells and improves nervous system signaling, Dompé is investigating whether intranasal NGF has the potential to improve movement and neurodevelopment and address underlying brain damage in people with CP. Dompé’s intranasal NGF platform builds on the Nobel Prize-winning discovery of neurobiologist Professor Rita Levi-Montalcini and biochemist Dr. Stanley Cohen. Dompé, a leading biopharmaceutical company with operations in Italy and in the U.S., announced that the first patient has been enrolled at the Agostino Gemelli IRCCS University Hospital in Rome, Italy, in a Phase 2 investigational study of an intranasal form of Nerve Growth Factor (NGF) (Cenegermin-bkb

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye